| Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention Z Younossi, QM Anstee, M Marietti, T Hardy, L Henry, M Eslam, J George, ... Nature reviews Gastroenterology & hepatology 15 (1), 11-20, 2018 | 4879 | 2018 |
| The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD P Angulo, JM Hui, G Marchesini, E Bugianesi, J George, GC Farrell, ... Hepatology 45 (4), 846-854, 2007 | 3588 | 2007 |
| A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement M Eslam, PN Newsome, SK Sarin, QM Anstee, G Targher, ... Journal of hepatology 73 (1), 202-209, 2020 | 3393 | 2020 |
| Telaprevir for previously untreated chronic hepatitis C virus infection IM Jacobson, JG McHutchison, G Dusheiko, AM Di Bisceglie, KR Reddy, ... New England Journal of Medicine 364 (25), 2405-2416, 2011 | 3284 | 2011 |
| MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease M Eslam, AJ Sanyal, J George, A Sanyal, B Neuschwander-Tetri, ... Gastroenterology 158 (7), 1999-2014. e1, 2020 | 2750 | 2020 |
| IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy V Suppiah, M Moldovan, G Ahlenstiel, T Berg, M Weltman, ML Abate, ... Nature genetics 41 (10), 1100-1104, 2009 | 2386 | 2009 |
| Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis Z Younossi, F Tacke, M Arrese, B Chander Sharma, I Mostafa, ... Hepatology 69 (6), 2672-2682, 2019 | 1730 | 2019 |
| NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome S Chitturi, S Abeygunasekera, GC Farrell, J Holmes-Walker, JM Hui, ... Hepatology 35 (2), 373-379, 2002 | 1553 | 2002 |
| Beyond insulin resistance in NASH: TNF‐α or adiponectin? JM Hui, A Hodge, GC Farrell, JG Kench, A Kriketos, J George Hepatology 40 (1), 46-54, 2004 | 1448 | 2004 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1123 | 2019 |
| Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression JM Hui, A Sud, GC Farrell, P Bandara, K Byth, JG Kench, GW McCaughan, ... Gastroenterology 125 (6), 1695-1704, 2003 | 996 | 2003 |
| Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss NA Johnson, T Sachinwalla, DW Walton, K Smith, A Armstrong, ... Hepatology 50 (4), 1105-1112, 2009 | 850 | 2009 |
| Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis HM Parker, NA Johnson, CA Burdon, JS Cohn, HT O’Connor, J George Journal of hepatology 56 (4), 944-951, 2012 | 753 | 2012 |
| Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis G Musso, R Gambino, JH Tabibian, M Ekstedt, S Kechagias, ... PLoS medicine 11 (7), e1001680, 2014 | 747 | 2014 |
| The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis K Kazankov, SMD Jørgensen, KL Thomsen, HJ Møller, H Vilstrup, ... Nature reviews Gastroenterology & hepatology 16 (3), 145-159, 2019 | 742 | 2019 |
| Visceral fat: a key mediator of steatohepatitis in metabolic liver disease D van der Poorten, KL Milner, J Hui, A Hodge, MI Trenell, JG Kench, ... Hepatology 48 (2), 449-457, 2008 | 712 | 2008 |
| Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates Z Younossi, M Stepanova, JP Ong, IM Jacobson, E Bugianesi, A Duseja, ... Clinical gastroenterology and hepatology 17 (4), 748-755. e3, 2019 | 705 | 2019 |
| Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study E Vilar-Gomez, L Calzadilla-Bertot, VWS Wong, M Castellanos, ... Gastroenterology 155 (2), 443-457. e17, 2018 | 700 | 2018 |
| Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection LA Adams, M Bulsara, E Rossi, B DeBoer, D Speers, J George, J Kench, ... Clinical chemistry 51 (10), 1867-1873, 2005 | 696 | 2005 |
| Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data G Leandro, A Mangia, J Hui, P Fabris, L Rubbia–Brandt, G Colloredo, ... Gastroenterology 130 (6), 1636-1642, 2006 | 683 | 2006 |
